Musculoskeletal disorders such as osteoporosis and rheumatoid arthritis are responsible for more than 25k deaths every year in the European Union and constitute a chronic burden on the individuals who suffer from this condition. There is no medical cure for these diseases and there are many therapies applied which have limited effectiveness and severe side effects over time. Regenerative therapies are being studied as a potential treatment for musculoskeletal diseases and are known for their upgrading effects of the natural healing processes carried out in the human body. It is believed that both strontium and zinc play an essential role in bone and cartilage tissue formation, which has led many scientists to study the effect of including these elements to promote tissue formation and inhibit its resorption.
Introduction
Bone and cartilage health and repair consist of maintaining the balance between tissue resorption and formation. Various musculoskeletal diseases such as Paget's disease, osteoarthritis, rheumatoid arthritis, osteogenesis imperfecta and osteoporosis derive from an imbalance of these processes. 1, 2 This group of diseases constitutes a major burden on individuals and health systems being responsible for more than 25k deaths every year in the European Union, 3 where 66% were women. 4 This situation encourages European research priorities to improve advanced therapies able to regenerate and restore tissues, organs and functions. 5 Tissue loss, particularly of bone and cartilage, continues to be a challenge; 6 recent statistics reveal that one in three women and one in five men will have an osteoporotic fracture over the age of fifty. 7 When bone tissue loss is present, fracture treatment carries important challenges due to the high risk of mortality in the first year. 8 The most common form of musculoskeletal disorders is osteoporosis, also known as ''primary osteoporosis'', which is the result of bone loss due to bone resorption, which consists mainly of the differentiation of a stromal cell/osteoblast or a macrophage into an osteoclast, 9 and deterioration of bone structure as people age. 10 It is believed that osteoclastic bone resorption is regulated by the RANKL/osteoprotegerin (OPG)/ RANK pathway, while osteoblastic bone formation is controlled by the canonical Wnt/b-catenin signalling pathway. [11] [12] [13] There are multiple risk factors for osteoporosis including sex, obesity, genetic predisposition, inflammation, stress and lifestyle. 14 The current therapies used for osteoporosis include: vitamin D and calcium supplements, bisphosphonates, teriparatide (TPH), hormone replacement therapy, selective oestrogen receptor modulators (SERMs), RANK ligand inhibitors and strontium ranelate, in which the safety issues and side effects are quite concerning. 15 Regenerative therapies imply the replacement or regeneration of human cells, tissues or organs with the purpose of returning the patient to full health, 16 by using concrete factors to upgrade the natural healing potential. 17 Currently there are still many diseases with no effective medical therapy which could be treated with tissue replacement. 18 Several strategies can be used: cell-based therapy, implantation of scaffolds seeded with cells and biomaterials which can be enriched with bioactive factors. 19 Strontium (Sr) is an alkaline earth element with close similarities with calcium (Ca) due to its bone-seeking properties. It has been found that vitamin D induces Sr absorption while Ca inhibits it. 20 Sr plays important physicochemical and biological roles in the application of bone repair materials; 21 it is known to be involved in the human bone mineral metabolism by inducing the expression of osteogenic-related genes, 22 differentiation markers, and proliferation and reducing apoptosis levels. 23 Moreover, Pasqualetti S. et al. have demonstrated that Sr also affects bone mineralization during skeletal development in zebrafish embryos. 24 For instance, strontium ranelate (SR) is currently used as a treatment against bone fractures in postmenopausal women. 25 Although slight toxicity in some of the patients was reported, 26 the latest studies report a low dose of Sr promotes osteogenesis, but high doses can, in explicit cases, induce apoptosis. 27 Additionally, Sr enriched biomaterials have been shown to induce osteogenesis and new bone formation ( Fig. 1) . 28 On the other hand, it is established that zinc (Zn) is an essential cofactor for enzymes involved in DNA, RNA and protein synthesis such as bone matrix components and is an essential component of the cell membrane repair machinery and musculoskeletal matrix regeneration. 29 The role of Zn in bone is twofold: firstly, Zn plays a structural role in the bone matrix and on the other hand, it is involved in the preservation of bone mass by stimulating bone formation by osteoblasts and inhibition of bone resorption by osteoclasts (Fig. 1) . 30 Furthermore, it has been confirmed that Zn deficiency leads to growth and gonadal development retardation, either for a deficient Zn intake or a defect in absorption. 31, 32 Not only does Zn act as an inhibitor of bone tissue loss but also plays an important role in cartilage II and SOX9 gene expression, cartilage matrix metabolism and inflammatory-related diseases carried out by Zn-dependent matrix metalloproteinases (MMPs). [33] [34] [35] [36] Since these two cations are easily available from accessible resources and they do not suffer degradation reactions during processing, storage and transport, there is an important research activity developing promising alternatives to more unstable, and sometimes prohibitive, growth factor and signalling biomacromolecule based therapies for real clinical applications. Thus, the aims of this review are to provide an expanded analysis of the scientific literature focused on the application of Sr and Zn as bioactive agents in musculoskeletal regenerative therapies in the last five years, and to deliver a valuable guide for a wide range of researchers in the fields of medicine, chemistry and material and pharmaceutical sciences interested in the biological role and significance of Sr and Zn containing materials in regenerative medicine.
Tissue engineering based on Zn and Sr containing scaffolds
Scaffolds have multiple applications and play an essential role in tissue engineering and can be obtained from a wide variety of fabrication procedures such as 3D printing, electrospinning, cryo-photo-redox-mediated polymerization or sintering. These scaffolds can be made from natural existing polymers, synthetic materials or combinations of both, in order to mimic the physicochemical and biological properties of the damaged or missing tissue by creation of an environment that promotes the capacity of cells to integrate, proliferate and differentiate. [37] [38] [39] A bioactive glass is a biocompatible material that can mimic human bone and induce re-growth. It also can be mixed with other materials such as Sr to promote its bioactivity. 40 49 The last four fabricated the bioactive glasses via the melt-quenching technique, which consists of a quenching consecutive to the fusion of two or more oxide components. 50 It is well known that the bone extracellular matrix (ECM) is composed of inorganic components such as hydroxyapatite crystals and organic components such as collagen, 51 which arrange into nanofibers controlling the behaviour of the cells. Hence, using nanofibers as a biomaterial is a wise decision as it mimics the situation in vivo. 52 (8Sr-HA and 50Sr-HA) and further along implanted into mice. 57 Bone cements are usually composed of two systems: powder (homopolymer PMMA (polymethyl methacrylate) + BPO (benzoyl peroxide)/ZrO 2 (zirconia)/BaSO 4 (barium sulphate)); and liquid (monomer MMA + hydroquinone + N,N-dimethyl para-toluidine (DMPT)). 58 Cui X. et al. 59 offered an innovative proposal by fusing these two concepts: bone cements and bioactive glasses, integrating a Sr containing borate bioactive glass (SrBG) into a bone cement in several concentrations: 10SrBG, 20SrBG and 30SrBG being 0.2, 0.4 and 0.6 g of SrBG respectively and comparing the results with a non-doped PMMA cement. This experiment was carried out on the MC3T3-E1 cell line as well as in vivo, in healthy and osteoporotic Sprague-Dawley rats. On the other hand, a Sr loaded bone cement (Sr-BC) was prepared in different concentrations Sr/(Ca + Sr) = 0%, 2%, 5% in a different study where the experiment was only carried out in vitro on the mouse monocyte cell line (RAW 264.7) and the MC3T3-E1 cell line. 60 Further, a cement precursor was found composed of 58 wt% a-tricalcium phosphate, 24 wt% calcium hydrogen phosphate, 8.5 wt% hydroxyapatite and 8.5 wt% strontium carbonate and later mixed with a 4% aqueous disodium hydrogen phosphate solution to assist new bone formation in Sprague-Dawley rats, 61 and silicon (Si) and Zn doped brushite cements (BrCs) alone and in combination with insulin like growth factor 1 (IGF-1), coming to four different scaffolds: (IGF-1) BrC, (IGF-1) Si-BrC, (IGF-1) Zn-BrC, and (IGF-1) Si/Zn-BrC cements, on New Zealand white rabbits. 62 Moreover, scaffolds from very different compositions were found: SrO doped biosilicate scaffolds, fabricated by mixing Mg 2 SiO 4 and CaSiO 3 and adding SrO in different ratios, being 0SrO (0 wt%), 0.5SrO (0.5 wt%), 1SrO (1 wt%), 2SrO (2 wt%), and 3SrO (3 wt%), were used to treat MG-63 cells; 63 [71] [72] [73] since it has been recently studied due to its biocompatibility and exclusive microstructure (Fig. 2) . The structure consists of crystalline strontium-hardystonite grains embedded with submicron gahnite crystals (prevents cracks). 74 The studies respectively carried out the experiments on human peripheral blood monocytes (hPBM), 71 adult stem cells (ASCs) and HUVEC cell lines 72 and, lastly, primary human osteoblasts (HOBs) and New Zealand white rabbits. 73 
Osteoinductive titanium surfaces containing Sr
Titanium (Ti) and its alloys have been used in a wide range of clinical applications such as orthopaedic and dental implants. Biocompatibility is the most significant property to be accomplished by a biomaterial to be used in any clinical application. We know that Ti is a chemically and mechanically stable, non-toxic, bone integrating material, 75 which however does not fulfil rapid osseointegration regenerative clinical use demands. 76 Different surface modifications have been recently described for inclusion of osteogenic elements. 77 On this subject, eight articles discussed the possibilities of doping titanium surfaces with Sr, well known for its possibilities to intensify bone regenerating features, such as SrTiO 3 /TiO 2 76 and Sr loaded titania nanotubes, 78 consisting of adding the Sr through a hydrothermal treatment. 79, 80 In both cases, the RAW 264.7 cell line was used for the experiment in vitro, although B. Mi et al. expanded their experiment in vivo, performing it on Sprague-Dawley rats (Fig. 3) . 78 Furthermore, the immune response to implanted biomaterials is imperative to apprehend whether a material is suitable or not. Knowing that Sr and Ca can induce osteogenesis and abolish inflammation, two papers were found which take advantage of these promising properties: BMSCs and RAW 264.7 cell lines were used in an experiment consisting of Sr and Ca co-doped titanium oxides, where numerous concentration ratios were used to go through the experiment: Ti, Ti-Ca10, Ti-Sr10, Ti-Ca10Sr10, Ti-Ca10Sr5 and Ti-Ca10Sr2.5, obtained by an electrochemical treatment of calcium chloride and strontium dichloride solutions on titanium plates 79 and Sr doped calcium (Ca)-and phosphate (P)-containing titanium oxide layers. The Ti oxide layers were modified by the micro-arc oxidation method (MAO), which is known for augmenting biocompatibility and osseointegration in vivo; 81 these Sr doped calcium (Ca)-and phosphate(P)-containing titanium oxide layers were also used further along for an experiment in vivo on C57BL/6 mice. In another study, electrolytes with different proportions of Sr: Sr-0M, Sr-0.05M, Sr-0.1M and Sr-0.15M were analysed using MC3T3E1 cells. 80 Calcium phosphate (CPS) coated titanium sheets, adding Sr 2+ by vertical immersion to reach varying concentrations of Sr 2+ in CPS (0, 10, and 1000 mM), were tested on hMSCs looking for osteogenic differentiation; 82 a SrO layer on a sandblasted large grit double acid etched (SLA) surface produced by hydrothermal treatment using a Sr containing solution was implanted into New Zealand white rabbits; 83 and lastly, titanium implants were induced to release Sr (Sr-Ti) or Mg (Mg-Ti) ions in Japanese white rabbits. 84 Sodium alginate (SA) is a promising and efficient biomaterial for bone formation and healing, 85, 86 and its utility in bone tissue regeneration has been studied as a coating with Sr and dopamine (DOPA) on a titanium (Ti) surface, which are well-known for their potential characteristics for bone tissue engineering; five samples were made: Ti, Ti/DOPA, Ti/DOPA/SA, Ti/DOPA/SA/Sr1 (1 wt% Sr) and Ti/DOPA/SA/Sr5 (5 wt% Sr) and tested using MG-63 cells. 
Strontium ranelate based therapies
Strontium ranelate (SR) is composed of two atoms of stable Sr combined with organic ranelic acid. It seems to have unique effects of inhibiting bone resorption as well as stimulating bone formation and it currently used as a treatment for osteoporosis and other bone diseases. 88 Since it has outstanding properties for bone tissue engineering, various authors decided to evaluate the effects of this compound (Fig. 4) 
Vehicles for zinc and strontium delivery
Microparticles (MPs) have been recently investigated for cartilage and bone regeneration using different materials; they also have the capacity to act as cell carriers by seeding the microparticles with cells before implantation. 97 For this matter, Sr/Zn doped microspheres were evaluated using Zn doped mesoporous hydroxyapatite microspheres (MHMs) to construct a novel biomimetic scaffold with the purposes of bone regeneration in BMSCs (Fig. 5) . Four scaffolds named: collagen (Coll) scaffold, MHM/Coll scaffold, Zn2-MHM/Coll scaffold, and Zn5-MHM/Coll were prepared and tested on an in vivo rat model. 98 Analogously, strontium polyphosphate microparticles (Sr-a-polyP-MP) were analysed to induce mineralization of bone cells in comparison to calcium polyphosphate microparticles (Ca-a-polyP-MP) and b-tricalcium phosphate (b-TCP), which were applied to Sarcoma Osteogenic cells (SAOS-2) and hMSC cells. These MPs were encapsulated in PGLA microspheres (MS), which leaves them with three samples to contrast: b-TCP-MS, Ca-a-polyP-MS, 99 and lastly, SR loaded PGLA microspheres (PM), where PGLA was degraded by hydrolysis into lactic and glycolic acid, which can develop into an inflammatory response. To this end, three samples were fabricated and contrasted: PM, SR-PM and SR-PM loaded with hydroxyapatite nanoparticles (SR-PM-HA), and MC3T3E1 cells were treated with them believing the microspheres with HA can neutralize the acidity of the lactic and glycolic acid. 100 
Composite materials loaded with zinc and strontium
As previously mentioned, Zn is crucial for growth and development. Although the pathways are not completely recognized, it has been shown that Zn has a protective effect on bone loss by enhancing bone formation and restraining bone resorption, having a therapeutic effect on bone disorders. 101 Additionally, the use of electromagnetic fields (EMFs) has shown curative effects in osteoporosis treatments. 102 (0.432 mg ml À1 ZnSO 4 and 50 Hz, 20 mT EMF exposure) and they were applied to ADSC cells. 103 The potential characteristics in osteoinduction of zinc silicate have been studied using different methods. One uses a reduced graphene oxide/zinc silicate/calcium silicate (RGO/ZS/CS) electroconductive biocomposite by spin-coating zinc silicate and strontium alginate (SA) onto a calcium silicate disk (ZS/CS disk), while simultaneously reducing graphite into reduced graphene oxide (RGO) and creating an RGO/SA suspension. Once everything was prepared, RGO/SA was spin coated onto ZN/CS disks and annealed at several temperatures, achieving RGO/ZN/CS biocomposites, which were further applied to BMSC cells. 104 Another uses willemite (ZnSiO 4 ) coated polymeric fibrous polyethersulphone-polyethylene glycol (PES-PEG) bioceramic nanoparticles. The PEG-PES fibers were fabricated by electrospinning followed by the immersion of the fibers into a 1 wt(%) Zn 2 SO 4 solution and they were used to treat SAOS and hMSC cells. 105 Additionally, particular methods were carried out in four of the analysed studies: Sr doped octacalcium phosphate (OCP) since it has been suggested that OCP is a precursor to biological apatite crystals, 106 This journal is © The Royal Society of Chemistry 2019 hybrid system composed of a RGD-alginate hydrogel cross-linked with Sr and reinforced with Sr doped hydroxyapatite microspheres was investigated in Wistar Han rats. 114 
Discussion and future perspectives
Throughout the article, the latest advances in strontium and zinc based regenerative therapies have been reviewed. These two cations have attracted the attention of several research groups due to their safety, easy accessibility and high stability conferring regenerative characteristics to biomaterials. Sixtyeight articles which performed an investigation using Sr and/or Zn regenerative therapies were analysed, within which a great variety of in vitro and in vivo studies have been conducted in order to test new therapies and bone osteogenic strategies.
As shown in Fig. S1 (ESI †), these papers were organized into five main groups according to the biomaterial that was used in each study. The studies performed in vitro were roughly composed of half performed on animal cell lines, and the other half on human cell lines. Most of them analysed bone formation by evaluating: cell morphology and proliferation; differentiation into osteoblasts; expression of osteoblastic-related genes such as: alkaline phosphatase (ALP), runt-related transcription factor 2 (Runx2), osteocalcin (Bglap), collagen type I a-chain (COL1), osteopontin (Spp1) and bone morphogenetic protein 2 (BMP2) by carrying out a PCR; and Ca deposition in the ECM. The inhibition of bone resorption was analysed by: inhibition of osteoclast formation (osteoclastogenesis) and inhibition of differentiation into osteoclasts. On the other hand, the studies performed in vivo were composed of only two papers performing an in vivo human study. Amongst the twenty-seven articles found, eleven carried out the experiment on rats; nine utilized rabbits; three used mice; one used a guinea pig and lastly, another one worked with a sheep. The majority concluded with promising results by analysing: bone repair, new and/or increased bone formation, biocompatibility, osteoconductivity, reduced risk of fracture and augmented tissue mineralization. In addition, most of the studies analysed the effect of Sr and/or Zn in femur or tibia areas in animals. Furthermore, excepting three articles in which two used Zn and the other one combined Sr and Zn; twenty-four of the studies performed in vivo used Sr as the main element to promote bone regeneration in osteoporotic -mostly induced -animal models. All these studies are summarized in Table 1 which helps to easily identify the method applied, element evaluated, tissues/cells targeted, and main results achieved from each study.
As the results showed for the in vitro studies, it is evident that Sr and Zn can not only induce osteogenesis and inhibit osteoclast formation, but also promote various processes such as calcification of the bone matrix and enhance osteogenicrelated genes that contribute to bone healing. The majority of the materials analysed resulted in bone formation or inhibition of bone resorption, obtaining as results: induction/enhancement of ALP activity of osteogenic related genes; osteoblastic differentiation or proliferation e.g. osteogenesis, angiogenesis, bone formation and osteoblastic formation among others; calcium deposition or mineralization of the ECM was also evaluated; inhibition of osteoclast formation or bone resorption; osteoblast attachment or enhanced cell adhesion; modulation of macrophage response or immunomodulation; and osteoblast protection against AGE.
A few drawbacks have been identified concerning vehiculation of divalent cations into biomaterials. Current evidence affirms that strontium ranelate mediates an uncoupling in bone turnover since it enhances osteogenesis and osteoblast activity while decreasing osteoclast differentiation and function; 116 but also that it has serious side effects such as memory loss or increased risk of venous thromboembolism. 15 However, new investigations substituting ranelic acid for vitamin-B derivatives of Sr or Zn are being recently described with very promising characteristics. 117 Biocompatibility is crucial in terms of regenerative therapies; most of the studies were carried out using Zn and/or Sr doped scaffolds (bioactive glasses, nanofibers. . .), Ti surfaces and Zn compounds, which appear to have exceptional biocompatibility. A Sr and Zn co-doped scaffold even achieved modulation of macrophage behaviour, 71 implying no rejection from the cells.
The Sr and/or Zn doped or loaded materials were able to stimulate a specific cellular response, thus exhibiting promising features to assist new bone formation, particularly relevant in the case of bone defects due to metabolic diseases, such as osteoporosis. Nonetheless, the weakness of the in vitro studies is that the data is complex to extrapolate due to the differences in the metabolism and drug development in distinct species and the different conditions of the surroundings when working in vivo.
On the other hand, the results from the in vivo studies also confirm that the addition of Sr and/or Zn can alter the physicomechanical characteristics and effectively enhance early stage in vivo osseointegration and recovery from bone turnover as well as tissue mineralization. The majority of the papers evaluated acceleration of early-stage bone formation/increased bone regeneration, yet some other results were pursued: recovery from bone resorption/turnover; augmented bone mass density (BMD); biocompatibility and osteoconductivity; enhanced tissue mineralization; decreased fracture incidence; early bone bonding, and prevented bone loss.
It should be noted that the one Sr and Zn co-doped scaffold concluded with the regeneration of bone in rabbit radial defects with no adverse effects. 73 Most of the biomaterials used demonstrated proper setting times and high mechanical strength, and released ion products (such as Ca, Sr, Zn and P), imparting bioactivity to the composite cement and confirming the cytocompatibility of the composites. Nevertheless, only two studies were performed in humans, thus the same problem is faced: differences in the metabolism and drug development in distinct species. Moreover, the experiments taking place in humans were performed with SR which is already being used as an antiosteoporotic treatment, meaning that the novel and innovative proposals of regenerative therapies are yet to be tested in humans.
The obtained results of the in vitro cell culture and the in vivo studies suggest that Sr and/or Zn have the potential to address the unmet need for bone substitutes that can be used in load and partial load-bearing sites in orthopedic applications as well as in osteoporotic defects, inducing bone formation to a level comparable to healthy animals at an ectopic site. In addition, the cellular mechanisms by which Sr and Zn induce osteogenesis and inhibit osteoclastogenesis are mediated through the RANKL/RANK system by suppressing RANKL-stimulation in osteoclastogenesis. From the results of the aforesaid studies, it can also be deduced that the osteogenic-induced effect carried out by the addition of Sr and/or Zn is dose-dependent, meaning that lower doses than the established may not be able to provide the desired effects and higher doses can have detrimental effects.
The role of Zn in cartilage protection promoting healthy collagen II production and conformation has been proven. 36 In addition, some authors have demonstrated that zinc can protect against the action of pro-inflammatory cytokines (1L-1b) through the activation of antioxidant genes preventing osteoarthritis. Controversially, elevated Zn levels lead to the activation of biochemical pathways in chondrocytes that result in catabolic function in chondrocytes upregulating the matrix metalloproteinases enzymes, thus demonstrating anti-inflammatory effects of Zn sequestrating regenerative approaches. 118 From the results of the aforesaid studies, it can also be deduced that the osteogenic-induced effect carried out by the addition of both Sr and/or Zn is dose-dependent, meaning that lower doses than the established may not be able to provide the desired effects and higher doses can have detrimental effects. In conclusion, current investigations demonstrate that strontium and zinc induce human stem cell differentiation towards cartilage and bone like phenotypes in vitro and biomaterials containing such enhanced their performance both in vitro and in vivo, inducing new bone and cartilage tissue formation and inhibiting tissue resorption. Thus, novel organic and inorganic bioactive derivatives of strontium and zinc are in continuous development in order to overcome some limitations related to existing drugs and delivery systems. These compounds, together with new insights about the use of strontium and zincbased biomaterials, confirm their potential to inspire advanced tissue engineering therapies for emerging regenerative medicine.
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